Source:http://linkedlifedata.com/resource/pubmed/id/16894461
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2006-8-8
|
pubmed:abstractText |
Blood coagulation factor XIII (FXIII) is a protransglutaminase circulating as a tetramer formed by two types of subunits (A2B2). The intracellular dimeric form of FXIII (A2) is present in platelets, megakaryocytes, monocytes and macrophages and has been detected in mono- and megakaryocytic leukemias. The aim of our study was to investigate FXIII-A expression in newly diagnosed B cell acute lymphoblastic leukemia (ALL) samples. We examined 47 de novo ALL cases of B cell origin by triple color labeling with flow cytometry. FXIII-A was detected by a FITC conjugated monoclonal antibody combined with CD34 and CD45 staining. In selected cases FXIII-A was investigated on slides prepared from blasts and visualized with a fluorescent microscope. In addition, blasts were studied by Western blot analysis and FXIII-A was measured by a highly sensitive ELISA method. By flow cytometry 19 samples of the 47 cases were found to be FXIII-A positive. Antigen concentration was 3.11 +/- 1.19 fg/blast, while normal lymphoid precursors and mature lymphocytes from B-CLL did not contain FXIII-A. In the lysate of lymphoblasts that were positive by flow cytometry, a single band (82 kDa) corresponding to FXIII-A was detected on Western blots. Confocal laser scanning microscopic examination revealed the presence of FXIII-A in the cytoplasm of these lymphoblasts. This novel expression site of FXIII-A in leukemic lymphoblasts can be utilized as a diagnostic tool and may also gain functional significance in B-lineage ALL.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0340-6245
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
96
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
176-82
|
pubmed:meshHeading |
pubmed-meshheading:16894461-Adolescent,
pubmed-meshheading:16894461-Adult,
pubmed-meshheading:16894461-Aged,
pubmed-meshheading:16894461-Child,
pubmed-meshheading:16894461-Child, Preschool,
pubmed-meshheading:16894461-Dimerization,
pubmed-meshheading:16894461-Factor XIII,
pubmed-meshheading:16894461-Flow Cytometry,
pubmed-meshheading:16894461-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:16894461-Humans,
pubmed-meshheading:16894461-Infant,
pubmed-meshheading:16894461-Leukemia,
pubmed-meshheading:16894461-Lymphocytes,
pubmed-meshheading:16894461-Macrophages,
pubmed-meshheading:16894461-Microscopy, Confocal,
pubmed-meshheading:16894461-Middle Aged
|
pubmed:year |
2006
|
pubmed:articleTitle |
Leukemic lymphoblasts, a novel expression site of coagulation factor XIII subunit A.
|
pubmed:affiliation |
Department of Clinical Biochemistry and Molecular Pathology, Thrombosis and Haemostasis Research Group of The Hungarian Academy of Sciences, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|